Skip to main content
Fig. 4 | Cardiovascular Diabetology

Fig. 4

From: Role of Canagliflozin on function of CD34+ve endothelial progenitor cells (EPC) in patients with type 2 diabetes

Fig. 4

The effect of Canagliflozin on CD34+ve cell Endothelial markers gene expression. Fold change in gene expression of Endothelial markers a VEGF-A, b KDR and c PECAM and endothelial function marker d NOS3 on CD34+ve cells increased significantly in Canagliflozin group from visit 1 to 3. However, the same for the placebo group is decreased. Gene expression is normalized to 18S

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840